# Functional Dyspepsia Treatment Trial

> **NCT00248651** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 292 (actual)

## Conditions studied

- Dyspepsia and Other Specified Disorders of Function of Stomach

## Interventions

- **DRUG:** Amitriptyline
- **DRUG:** Escitalopram
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00248651
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2014-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00248651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00248651, "Functional Dyspepsia Treatment Trial". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00248651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*